Advances in the application of anti-inflammatory and liver-protecting drugs in treatment of autoimmune hepatitis
Autoimmune hepatitis (AIH) is the first liver disease which has proved responsive to glucocorticoids, and the standard therapeutic method is hormone combined with azathioprine. Given that some patients fail to reach the standard of immunosuppressive therapy, and the long-term use of immunosuppressiv...
Main Authors: | ZHANG Hongxia, ZHOU Lu, WANG Bangmao |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2017-03-01
|
Series: | Linchuang Gandanbing Zazhi |
Subjects: | |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=8155 |
Similar Items
-
Current status and recent progress of second-line drugs for autoimmune hepatitis
by: HU Zhichao
Published: (2018-05-01) -
Advances in diagnosis and treatment of autoimmune hepatitis
by: WANG Qianyi
Published: (2015-02-01) -
Research advances in non-hormonal therapies for autoimmune hepatitis
by: ZHONG Qihua, et al.
Published: (2016-02-01) -
Autoimmune liver disease and therapy in childhood
by: Matjaž Homan
Published: (2013-10-01) -
The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis
by: Hye Young Ju, et al.
Published: (2012-06-01)